Catalyst Biosciences Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Catalyst Biosciences

Access the complete profile.

Catalyst Biosciences Fast Facts

Revenue	Less than $1 million    See Exact Annual Revenue
Employees	1 - 10Exact Company Size
Primary Industry	339112 Surgical & Medical Instrument Manufacturing
Address	611 Gateway Blvd Ste 120 South San Francisco, CA 94080

Note: Revenues for privately held companies are statistical evaluations.


Catalyst Biosciences's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Catalyst Biosciences's annual revenues are Less than $1 million (see exact revenue data)
• What industry is the company in?
  • Catalyst Biosciences is classified as operating in the Surgical & Medical Instrument Manufacturing industry, NAICS Code 339112.

Catalyst Biosciences Annual Revenue and Growth Rate

Catalyst Biosciences	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	Less than $1 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Catalyst Biosciences's revenues are gauged from an analysis of company filings.

Catalyst Biosciences's Income Statement (based on Industry Averages)

Catalyst Biosciences P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Catalyst Biosciences is developing and marketing. Catalyst Biosciences doesn't have any recent trademark applications, indicating Catalyst Biosciences is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
PROTUNE Research and development in the field of biotechnology; pharmaceutical research into new drugs and development of drugs; scientific and technical research services in the field of biotechnology, hematology, blood disorders, neurology, inflammation, immunology, oncology, skin disorders, autoimmune disease, infectious diseases and genetic diseases; industrial analysis and research services in the field of biotechnology, hematology, neurology, inflammation, immunology, oncology, skin disorders, autoimmune disease, infectious diseases and genetic diseases; providing information and advice in relation to the aforementioned services, namely, providing scientific information and advice relating to biotechnology, pharmaceutical research, and scientific and technical research; providing scientific and medical research information in the field of pharmaceuticals; pharmaceutical research and development services; product research and development services	11/30/2021
IMMUNOTUNE Research and development in the field of biotechnology; pharmaceutical research into new drugs and development of drugs; scientific and technical research services in the field of biotechnology, hematology, blood disorders, neurology, inflammation, immunology, oncology, skin disorders, autoimmune disease, infectious diseases and genetic diseases; industrial analysis and research services in the field of biotechnology, hematology, neurology, inflammation, immunology, oncology, skin disorders, autoimmune disease, infectious diseases and genetic diseases; providing information and advice in relation to the aforementioned services, namely, providing scientific information and advice relating to biotechnology, pharmaceutical research, and scientific and technical research; providing scientific and medical research information in the field of pharmaceuticals; pharmaceutical research and development services; product research and development services	11/30/2021
ALTERASE Biochemicals, namely, proteases for use in human therapeutics, namely, for the treatment of infectious, auto-immune, cell-proliferative, inflammatory, metabolic, cardiovascular, respiratory, neurological, and musculoskeletal disorders and diseases	03/28/2006

See all trademarks and details in the Full Report.

Market Share of Catalyst Biosciences's Largest Competitors

A competitive analysis shows these companies are in the same general field as Catalyst Biosciences, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
EMBECTA	Parsippany, NJ	100
STRUCTURE MEDICAL	Mooresville, NC	34
AUTOCAM MEDICAL DEVICES	Kentwood, MI	30
SCHARNBERG HOLDING	Des Moines, IA	26
SPECIALTY SURGICAL INSTRUMENTATION	Antioch, TN	24
MIDWEST INTERVENTIONAL SYSTEMS	Maple Grove, MN	19
VITA NEEDLE	Needham, MA	17
PYLANT MEDICAL	Grapevine, TX	17
MEDTEC	Orange City, IA	16

Nearby Competitors

These companies are similar in business line and location to Catalyst Biosciences. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
INTUITIVE SURGICAL	Sunnyvale, CA	100
NEVRO	Redwood City, CA	10
ACCURAY	Sunnyvale, CA	6
CUTERA	Brisbane, CA	5
THREAD ROBOTICS	Mountain View, CA	4
CONCEPTUS	Mountain View, CA	4

Other Companies at 611 Gateway Blvd Ste 120, South San Francisco CA

Company	Headquarters	Revenue ($ MM)
DS-INTERPRETATION	South San Francisco, CA	100
LINGUAMARINA	South San Francisco, CA	0
CAPTUREPROOF	South San Francisco, CA	0
BALMERE SKIN	South San Francisco, CA	0
CELLCHORUS	South San Francisco, CA	0

Future Competition: Catalyst Biosciences's Fastest Growing Competitors

These companies are in the same general field as Catalyst Biosciences and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)